Urinary excretion of α-hydroxytriazolam following a single dose of Halcion®

Journal of Analytical Toxicology

Volumn 29, Issue 2, 2005, Pages 118-123

  Lin, Dong Liang ^a,b,c   Huang, Tsun Ying ^a,b   Liu, Hsiu Chuan ^a,b   Yin, Rea Ming ^a  

^a Ministry of Justice   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c Taiwan Society of Forensic Medicine   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYTRIAZOLAM; DRUG METABOLITE; TRIAZOLAM; UNCLASSIFIED DRUG;

ACCURACY; ADULT; ARTICLE; CASE REPORT; DERIVATIZATION; DRUG URINE LEVEL; FEMALE; GAS CHROMATOGRAPHY; HUMAN; HYDROLYSIS; MALE; MASS SPECTROMETRY; URINALYSIS; URINARY EXCRETION;

EID: 15244362774     PISSN: 01464760     EISSN: None     Source Type: Journal    
DOI: 10.1093/jat/29.2.118     Document Type: Article

References (16)

1. A. Steentoft and K. Worm. Triazolan (Halcion) poisoning. Ugeskr Laeger 153: 500-503 (1991).
2. G. Koves and J. Wells. The quantitation of triazolam in postmortem blood by gas chromatography/negative ion chemical ionization mass spectrometry. J. Anal. Toxicol. 10: 241-244 (1986).
3. T.S. Bal, B. Johnson, E.A. Kilner, J.P. Sunter, and W.K. Cowan. Three deaths involving triazolam-analytical aspects. J. Forensic Sci. Soc. 28: 119-123 (1989).
4. K. Uemura and S. Komura. Death caused by triazolam and ethanol intoxication. Am. J. Forensic Med. Pathol. 16: 66-68 (1995).
5. B. Levine, A. Grieshaber, J. Pestaner, K.A. Moore, and J.E. Smialek. Distribution of triazolam and α-hydroxytriazolam in a fatal intoxication case. J. Anal. Toxicol. 26: 52-54 (2002).
6. R.B. Smith, P.D. Kroboth, and P.D. Varner. Pharmacodynamics of triazolam after intravenous administration. J. Clin. Pharmacol. 27: 971-979 (1987).
7. K. Otani, N. Yasui, H. Furukori, S. Kaneko, H. Tasaki, T. Ohkubo, T. Nagasaki, K. Sugawara, and K. Hayashi. Relationship between single oral dose pharmacokinetics of alprazolam and triazolam. Int. Clin. Psychopharmacol. 12: 153-157 (1997).
8. F.S. Eberts, Jr., Y. Philopoulos, L.M. Reineke, and R.W. Vliek. Triazolam disposition. Clin. Pharmacol. Ther. 29: 81-93 (1981).
9. K. Kudo, T. Nagata, K. Kimura, T. Imamura, and N. Urakawa. Postmortem changes of triazolam concentrations in body tissues. Nippon Hoigaku Zasshi 46: 293-296 (1992).
10. A.D. Fraser and R. Meatherall. Comparative evaluation of five immunoassays for the analysis of alprazolam and triazolam metabolites in urine. J. Anal. Toxicol. 20: 217-223 (1996).
11. W.A. Joern. Confirmation of low concentraction of urinary benzodiazepines, including alprazolam and triazolam, by GC/MS: an extractive alklation procedure. J. Anal. Toxicol. 16: 363-367 (1992).
12. E.R. Cairns, B.R. Dent, J.C. Ouwerkerk, and L.J. Porter. Quantitative analysis of alprazolam and triazolam in hemolysed whole blood and liver digest by GC/MS/NCl with deuterated internal standards. J. Anal. Toxicol. 18: 1-6 (1994).
13. L.E. Edinboro and A. Poklis. Detection of benzodiazepines and tribenzazolams by TRIAGE: confirmation by solid-phase extraction utilizing SPEC.3ML.MP3 microcolumns and GC-MS. J. Anal. Toxicol. 18: 312-316 (1994).
14. R. Meatherall. Optimal enzymatic hydrolysis of urinary benzodiazepine conjugates. J. Anal. Toxicol. 18: 382-384 (1994).
15. A.D. Fraser, W. Bryan, and A.F. Isner. Urine screening for-OH triazplam by FPIA and EIA and confirmation by GC/MS. J. Anal. Toxicol. 16: 347-350 (1992).
16. 9-tetrahydrocannabinol-9-carboxylic acid in urine specimens. Forensic Sci. Int. 49: 43-56 (1991).